Clinical Trial

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

Study acronym: INFER 2
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-24.
Trial Details
NCT Number NCT06851130
Lead Sponsor Swiss Federal Institute of Technology
Conditions Iron Deficiency Without Anemia
Enrollment 120 participants
Start Date 2025-02-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-20